A CpG 1018S/QS-21-Adjuvanted HBsAg Therapeutic Vaccine as a Novel Strategy Against HBV

Chronic hepatitis B virus (HBV) infection remains a major global health challenge, substantially contributing to liver-related morbidity and mortality. <b>Background/Objectives</b>: Developing therapeutic strategies that overcome immune tolerance and achieve functional cures is an urgent...

Full description

Bibliographic Details

Published in:	Vaccines
Main Authors:	Zixuan Wang, Jing Wu, Xiaohan Meng, He Weng, Qiang Li, Lin Li, Zhenhao Ma, Sirong Bi, Qiuju Han, Huajun Zhao, Cunbao Liu, Deping Meng
Format:	Article
Language:	English
Published:	MDPI AG 2025-09-01
Subjects:	chronic hepatitis B therapeutic vaccine adjuvant CpG 1018 QS-21 immune tolerance
Online Access:	https://www.mdpi.com/2076-393X/13/10/1014